Dian Tjahyadi

No ORCID on file · 11 papers in corpus · active 2022-2026

Study types

  • article 6
  • review 2
  • book-chapter 1
  • case-report 1
  • other 1

Condition tags

  • adenomyosis 7
  • endometriosis 6
  • dysmenorrhea 3
  • infertility 3
  • chronic_pelvic_pain 2
  • dyspareunia 1
  • endometrioma 1
  • mesh:D004715 1
case-report 2026
International medical case reports journal ·doi:10.2147/IMCRJ.S560694

BACKGROUND: The etiology of adenomyosis remains uncertain, and factors such as pregnancy, postpartum endometritis, cesarean delivery, uterine surgery, and uterine trauma are suspected to cause myometrial disruption that may trigger smooth m…

book-chapter 2026
·doi:10.5772/intechopen.1015068

Endometriosis is an enigmatic disease affecting approximately 10% of the population. This unique disease is often chronic and characterized by inflammation. Even though endometriosis and its related disease, adenomyosis, are benign tumors, …

article 2026
·doi:10.2147/ijwh.s604715

Background: Endometriosis is a chronic inflammatory condition, causing severe pelvic pain, organ dysfunction, infertility, and mental health issues. Ovarian reserve, indicating the quantity and quality of a woman's oocytes, is negatively af…

other 2025
Scientific reports ·doi:10.1038/s41598-024-85017-4

Endometriosis is a chronic inflammatory disease characterized by the presence of endometrial-like tissues (glands and stroma) located outside the uterine cavity. The pathophysiology of this condition remains incompletely understood. Local b…

review 2025
·doi:10.36129/jog.2025.226

Background: Adenomyosis is a benign uterine disease characterized by the presence of endometrial glands and stroma in the myometrium.It lacks classic physical or laboratory examination findings, which hinders clinical diagnosis.Although unl…

review 2025
International journal of reproductive biomedicine ·doi:10.18502/ijrm.v23i9.20156

Background: Elagolix, Linzagolix, and Relugolix, as oral gonadotropin-releasing hormone antagonists, have emerged as promising treatments for endometriosis-associated pain. Objective: To evaluate pain intensity reduction as the primary outc…

article 2025
·doi:10.24198/obgynia.v8i2.890

Objective: This study aims to translate, develop, and assess the validity and reliability of the Indonesian version of Professor Chapron’s screening method for endometriosis diagnosis based on the questionnaire as a tool for better endometr…

article 2025
·doi:10.24198/obgynia.v8i3.931

Introduction: Adenomyosis, a benign uterine condition characterized by endometrial tissue within the myometrium, leads to uterine enlargement, infertility, dysmenorrhea, and heavy menstrual bleeding. While its precise etiology remains elusi…

article 2024
Obstetrics & gynecology science ·doi:10.5468/ogs.24021

OBJECTIVE: This study aimed to investigate the levels of chitinase-3-like protein-1 (CHI3L1), matrix metalloproteinase-9 (MMP-9), and monocyte chemoattractant protein-1 (MCP-1) in adenomyosis, as compared to normal myometrial tissue. These …

article 2024
Annals of medicine and surgery (2012) ·doi:10.1097/ms9.0000000000001718

Background: Adenomyosis is a gynaecological condition characterized by the infiltration of endometrial glands and stroma resulting in ectopic intramyometrial, leading to the generalized enlargement of the uterus. Various cyclical regimens a…

article 2022
Annals of medicine and surgery (2012) ·doi:10.1016/j.amsu.2022.104620

Introduction: Adenomyosis (benign gynecological disease) is an endometrial stromal tissue condition that invades the myometrium of the uterus. The administration of a gonadotropin-releasing hormone (GnRH) analog before the IVF (In Vitro Fer…